Does it Matter Whether Canada’s Separate Health Technology Assessment Process for Cancer Drugs has an Economic Rationale?

Does it Matter Whether Canada’s Separate Health Technology Assessment Process for Cancer Drugs has an Economic Rationale?

Bibliographic Details
Main Authors: Hoch, Jeffrey S., Beca, Jaclyn, Sabharwal, Mona, Livingstone, Scott W., Fields, Anthony L. A.
Format: Online
Language:English
Published: Springer International Publishing 2015
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4519630/
id pubmed-4519630
recordtype oai_dc
spelling pubmed-45196302015-08-03 Does it Matter Whether Canada’s Separate Health Technology Assessment Process for Cancer Drugs has an Economic Rationale? Hoch, Jeffrey S. Beca, Jaclyn Sabharwal, Mona Livingstone, Scott W. Fields, Anthony L. A. Letter to the Editor Springer International Publishing 2015-05-05 2015 /pmc/articles/PMC4519630/ /pubmed/25939500 http://dx.doi.org/10.1007/s40273-015-0278-7 Text en © The Author(s) 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
repository_type Open Access Journal
institution_category Foreign Institution
institution US National Center for Biotechnology Information
building NCBI PubMed
collection Online Access
language English
format Online
author Hoch, Jeffrey S.
Beca, Jaclyn
Sabharwal, Mona
Livingstone, Scott W.
Fields, Anthony L. A.
spellingShingle Hoch, Jeffrey S.
Beca, Jaclyn
Sabharwal, Mona
Livingstone, Scott W.
Fields, Anthony L. A.
Does it Matter Whether Canada’s Separate Health Technology Assessment Process for Cancer Drugs has an Economic Rationale?
author_facet Hoch, Jeffrey S.
Beca, Jaclyn
Sabharwal, Mona
Livingstone, Scott W.
Fields, Anthony L. A.
author_sort Hoch, Jeffrey S.
title Does it Matter Whether Canada’s Separate Health Technology Assessment Process for Cancer Drugs has an Economic Rationale?
title_short Does it Matter Whether Canada’s Separate Health Technology Assessment Process for Cancer Drugs has an Economic Rationale?
title_full Does it Matter Whether Canada’s Separate Health Technology Assessment Process for Cancer Drugs has an Economic Rationale?
title_fullStr Does it Matter Whether Canada’s Separate Health Technology Assessment Process for Cancer Drugs has an Economic Rationale?
title_full_unstemmed Does it Matter Whether Canada’s Separate Health Technology Assessment Process for Cancer Drugs has an Economic Rationale?
title_sort does it matter whether canada’s separate health technology assessment process for cancer drugs has an economic rationale?
description
publisher Springer International Publishing
publishDate 2015
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4519630/
_version_ 1613253896354922496

Similar Items